Genomics is the study of the complete genetic material, including genes and their functions, of an organism. Current public health efforts focus specifically on Lynch Syndrome and Hereditary Breast and Ovarian Cancer syndrome (HBOC) due to mutations in BRCA1 or BRCA2 genes. According to most recent estimates, 55-65% of women will inherit a harmful BRCA1 mutation and around 45% of women will inherit BRCA2 mutation will develop cancer by age 70. Among those with Lynch syndrome, the lifetime risk of colorectal and uterine cancers vary widely depending on the specific mutation(s) and can be as high as 71%.
– Huntsman Cancer Institute and Intermountain Healthcare have instituted tumor screening protocols to assess for Lynch syndrome in all resected colon and endometrial cancers. Researchers at Huntsman Cancer Institute are pursuing multiple studies to further define the cancer risks associated with genetic mutations conferring. mild/moderate cancer risks and to assess patient understanding of, desire for, and medical management impact of this type of genetic information.
UCAN’s supports the organizations working to increase awareness of genetic mutations and appropriate use of genetic counseling as well research efforts to expand cancer genomics knowledge of genetic factors that increase cancer risk.
– Huntsman Cancer Institute and Intermountain Healthcare have instituted tumor screening protocols to assess for Lynch syndrome in all resected colon and endometrial cancers. Researchers at Huntsman Cancer Institute are pursuing multiple studies to further define the cancer risks associated with genetic mutations conferring. mild/moderate cancer risks and to assess patient understanding of, desire for, and medical management impact of this type of genetic information.
UCAN’s supports the organizations working to increase awareness of genetic mutations and appropriate use of genetic counseling as well research efforts to expand cancer genomics knowledge of genetic factors that increase cancer risk.
– Huntsman Cancer Institute and Intermountain Healthcare have instituted tumor screening protocols to assess for Lynch syndrome in all resected colon and endometrial cancers. Researchers at Huntsman Cancer Institute are pursuing multiple studies to further define the cancer risks associated with genetic mutations conferring. mild/moderate cancer risks and to assess patient understanding of, desire for, and medical management impact of this type of genetic information.
UCAN’s supports the organizations working to increase awareness of genetic mutations and appropriate use of genetic counseling as well research efforts to expand cancer genomics knowledge of genetic factors that increase cancer risk.